药物经济学研究在国内已开展数年,并逐渐引起医学界、药学界及政府有关部门的兴趣和重视。近年来,一些高等医药院校、研究机构的学者和外资制药企业先后投入人力、物力开展了药物经济学研究。但PE作为一门新兴的边缘学科,在许多方面还不成熟。对此,本文作者从药物经济学研究的应用,借鉴国外经验,以及我国药物经济学研究存在的主要问题等方面,就在我国今后如何开展药物经济学研究,如何充分发挥其作用提出了自已的看法和建议。 Pharmacoeconomic research has been carried out in China for several years, and gradually aroused the interest and attention of medical circles, pharmacy circles and relevant government departments. In recent years, some colleges and universities, research institutes and foreign-funded pharmaceutical enterprises have invested manpower and material resources in the study of pharmacoeconomics. However, PE as an emerging edge discipline is not yet mature in many aspects. In this regard, the author of this article from the application of drug economics, learn from foreign experience, as well as the main problems in the study of drug economics in China in the future how to carry out the study of drug economics, how to give full play to its role put forward their own Opinions and suggestions.